Healthcare - Biotechnology - NASDAQ - US
$ 0.323
-7.32 %
$ 2.82 M
Market Cap
0.0
P/E
CASH FLOW STATEMENT
-18.6 M
OPERATING CASH FLOW
-14.4 K
INVESTING CASH FLOW
15.9 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Aditxt, Inc.
| Net Income | -32.4 M |
| Depreciation & Amortization | 543 K |
| Capital Expenditures | -14.4 K |
| Stock-Based Compensation | 1.4 M |
| Change in Working Capital | 9.1 M |
| Others | 4.89 M |
| Free Cash Flow | -18.6 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||
| Net Income | (32.4) | (27.6) | (46.4) | (9.1) | (5.8) | (5.7) | (0.9) |
| Depreciation & Amortization | 0.5 | 0.5 | 0.5 | 17.8 K | 0 | 0 | 0 |
| Deferred Income Tax | 0 | 0 | 17.0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation | 1.4 | 3.1 | 4.6 | 3.2 | 4.2 | 3.5 | 0.6 |
| Other Operating Activities | 2.8 | 2.1 | 1.8 | 0.3 | 0.5 | 0.4 | 34.3 K |
| Change in Working Capital | 9.1 | (0.5) | 0.1 | (1.6) | 1.1 | 1.4 | 0.2 |
| Cash From Operations | (18.6) | (22.4) | (22.3) | (7.2) | (0.5) | (0.4) | 0 |
| INVESTING CASH FLOW | |||||||
| Capital Expenditures | 14.4 K | (0.4) | (1.0) | (0.2) | 0 | 0 | 0 |
| Other Items | 0 | 0.1 | (15.3) | 0 | 0 | 0 | 0 |
| Cash From Investing Activities | 14.4 K | (0.2) | (16.3) | (0.2) | 0 | 0 | 0 |
| FINANCING CASH FLOW | |||||||
| Common Stock Repurchased | 1 K | 20 K | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 7.6 | 2.4 | 3.6 | (0.3) | 2 K | 0.1 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (2.8) | 15.1 | 2.5 | (0.3) | (0.1) | (0.5) | 100 K |
| Cash From Financing Activities | 15.9 | 17.5 | 36.0 | 17.9 | 0.4 | 0.5 | 100 K |
| CHANGE IN CASH | |||||||
| Net Change In Cash | (2.7) | (5.1) | (2.6) | 10.5 | (0.1) | 90.7 K | 100 K |
| FREE CASH FLOW | |||||||
| Free Cash Flow | (18.6) | (22.8) | (23.3) | (7.4) | (0.5) | (0.4) | 0 |